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Free and membrane-bound polyribosomes were isolated from the livers of untreated and clotibrate-treated male C57Bl/6 
mice. The in vitro translation products were investigated in a rabbit reticulocyte cell-free system by immunoprecipitation 
of cytosolic epoxide hydrolase, catalase and albumin. The soluble forms of epoxide hydrolase present in cytosol and in 
peroxisomes were found to be synthesized on free polyribosomes and could not be distinguished from each other, since 
only one primary translation product was found with the methods used. Clofibrate treatment was found to increase total 
protein synthesis, synthesis of soluble epoxide hydrolase and translational efficiency of the isolated polyribosomes. 
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1. INTRODUCTION 
Epoxide hydrolases (EC 1.11.1.6) have impor- 
tant functions in the cellular metabolism of xeno- 
biotics and endogenous compounds due to their 
ability to transform reactive epoxides into the more 
polar and less reactive products, dihydrodiols [ 11. 
The soluble forms of epoxide hydrolase in the 
cytosol and in peroxisomes differ in substrate 
specificity, structure and genetic regulation from 
the microsomal xenobiotic-metabolizing epoxide 
hydrolase (review [l]), which furthermore is 
distinct from the microsomal cholesterol oxide 
hydrolase [2]. 
The cytosolic and peroxisomal forms of epoxide 
hydrolase seem to be closely related, having similar 
catalytic, immunochemical and structural proper- 
ties [I]. Our interest in the regulation of these solu- 
ble forms of epoxide hydrolase has led us to work 
with peroxisome proliferators. No investigations 
concerning the cellular synthesis of soluble forms 
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of epoxide hydrolase have been published so far, 
however. In an initial attempt to study regulation 
we therefore decided to carry out an investigation 
to determine on which type of polyribosomes the 
synthesis of soluble forms of epoxide hydrolase oc- 
curs, to ascertain whether the immediate transla- 
tion products can differentiate between the 
cytosolic and peroxisomal forms, and to elucidate 
the effects of clofibrate on the translation of epox- 
ide hydrolase and total protein, using catalase as a 
marker protein for effects on peroxisomes. 
2. MATERIALS AND METHODS 
Clofibrate (ICI PLC, Macclesfield, England), protein A- 
Sepharose (Pharmacia-LKB, Uppsala), acrylamide and bis- 
acrylamide (BDH, Poole, England), phenylmethylsulfonyl 
fluoride (PMSF) (Sigma, St. Louis, MO), heparin (Kabi 
Vitrum, Stockholm), L-1-chloro-3-(4-tosylamido)-7-amino-2- 
heptanone hydrochloride (TLCK) and L-1-chloro-3-(4-tosyl- 
amino)-4-phenyl-2-butanone (TPCK) (Merck, Darmstadt), and 
[%]-methionine (about 1250 Ci/mmol) and immunopurified 
[“‘I]-protein A (30 mCi/mg) (Amersham International, Amers- 
ham, England) were all purchased from the sources indicated: 
Male C57Bl/6 mice (about 20 g, equivalent o 8 weeks of age) 
(ALAB, Sollentuna, Sweden) were used. Induction was per- 
formed by feeding mice for 7 days on the normal diet containing 
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0.5% clofibrate. This treatment ensures maximal induction of 
cytosolic epoxide hydrolase in liver [3]. Male Sprague-Dawley 
rats (180-200 g) (ALAB) were used to prepare liver cytosol con- 
taining an endogenous RNase inhibitor. 
Epoxide hydrolase activity towards truns-stilbene oxide [4], 
catalase activity [5], carnitine acetyltransferase activity [6] and 
protein [7] was determined as described. Total RNA was ex- 
tracted from liver homogenates and assayed as in [8]. The RNA 
content of polyribosomes was measured by the absorbance at 
260 nm (assuming 1 &a=40 ,ug RNA). Immunotransfer was 
performed as described [9] after electrophoretic separation of 
samples according to Laemmli [lo]. Cytosolic epoxide hydro- 
lase was purified from clofibrate-treated mice and antibodies 
were raised in rabbits as in [ll]. IgG was purified from the 
serum by using protein A-Sepharose. 
Free and membrane-bound polyribosomes were isolated 
essentially as described and stored at -80°C [12-141. Disruption 
of livers was routinely performed by homogenizing livers in a 
Potter-Elvehjem homogenizer using four up-and-down strokes 
at 440 rpm. This treatment disrupts essentially only hepatocytes 
while endothelial cells remain unaffected and minimal damage 
occurs to lysosomes [15]. Rat liver was homogenized in the same 
way and the cytosol prepared [12] was routinely stored at 
- 80°C. Parts of livers were also used for preparation of dif- 
ferent subcellular fractions [16] for immunochemical analysis 
and other assays. 
A rabbit reticulocyte lysate was prepared as in [17]. The reac- 
tion mixture contained 0.1 mM unlabelled amino acids and 1 
PM [“Slmethionine (1 mCi/ml). The reaction was followed by 
spotting aliquots on filter papers and terminated by addition of 
SDS to a final concentration of 4% and heating to 100°C for 3 
min. A solution containing PMSF, TPCK, TLCK and trasylol 
was added and the mixture centrifuged whereupon the super- 
natants were carefully removed. Supernatant fractions were 
first treated with protein A-Sepharose. After centrifugation, the 
supernatant was treated with 50 fig preimmune IgG for 1 h at 
room temperature, protein A-Sepharose added thereafter, and 
further incubation performed for 30 min before centrifugation. 
The resulting supernatant was incubated with IgG against cyto- 
solic epoxide hydrolase overnight at 4°C before addition of pro- 
tein A-Sepharose and centrifugation. This procedure was 
repeated sequentially with IgG against catalase and albumin. 
The immunoprecipitates were extensively washed before 
analysis by SDS-polyacrylamide gel electrophoresis. After elec- 
trophoresis [lo] gels were stained with Coomassie blue and 
treated with 1 M salicylate or 20% 2,5-diphenyloxazole and 
fluorographed at - 80°C. Bands corresponding to the different 
proteins were excised, dissolved and decolorized before addition 
of acidified scintillation cocktail. 
3. RESULTS 
Greater amounts of polyribosomes from mouse 
liver were required to reach maximal incorporation 
as compared to rat liver polyribosomes (where con- 
centrations over 50 A&ml do not result in any in- 
crease in incorporated radioactivity, unpublished). 
For free polyribosomes, a slight increase in incor- 
84 
porated radioactivity could be observed up to 80 
&W/ml (fig.lA,B), although the radioactivity in- 
corporated, calculated per A260 UUit, aCtUa]]y de- 
creased lo-20%. A higher translational efficiency 
was observed for polyribosomes isolated from 
clofibrate-treated animals vs those from controls. 
Membrane-bound polyribosomes supported lower 
incorporation of radioactivity, only slightly above 
the background of the nuclease-treated lysate. 
Again, membrane-bound polyribosomes from 
clofibrate-treated animals had higher translational 
efficiency (fig. lA,B). Similar results were obtain- 
ed when polyribosomes isolated by magnesium 
precipitation were analyzed. 
Immunoblot analysis of hepatic fractions from 
untreated mice showed a single band of molecular 
mass 60 kDa for soluble epoxide hydrolase 
(fig.2A). Analysis of liver fractions with catalase 
antibodies (fig.2B) revealed proteolysis in the 
homogenate and light mitochondrial fraction, 
whereas the cytosol only contained mature 
catalase, in accordance with other work [18]. 
The soluble forms of epoxide hydrolase were 
found to be synthesized on free polyribosomes in 
mouse liver (fig.2A, lane 5). Only one band was 
observed in the region of interest on the gels. Upon 
prolonged exposure, however, some low molecular 
mass products appeared (fig.2A), which may repre- 
sent cross-reacting antigens. Membrane-bound 
polyribosomes were analyzed and showed 
4-15fold lower relative expression of soluble epox- 
ide hydrolase. Synthesis of catalase was also 
observed to be on free polyribosomes from mouse 
liver, as expected (fig.ZB, lane 4). Only mature 
catalase was found in this case. The translatability 
of catalase from membrane-bound polyribosomes 
was found to be 3-g-fold lower. Synthesis of 
albumin was found to take place on membrane- 
bound polyribosomes, as expected (fig.2C). Trans- 
lation products derived from free polyribosomes 
also reacted with the albumin antibodies, however 
the relative expression was 4-13-fold lower vs 
membrane-bound polyribosomes. 
Clofibrate treatment for 7 days was found to af- 
fect several hepatic parameters examined (table 1). 
The hepatomegalic effect is reflected in the pro- 
nounced increase in liver weight. The increase in 
total activity of soluble forms of epoxide hydrolase 
was found to be 295% of control levels, while that 
in catalase activity was less pronounced (185% of 
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Fig.1. Effects of polyribosomal concentration on incorporation of radioactivity. (A) Free polyribosomes [38 (B), 64 (*) and 84 (A) 
A&ml] and membrane-bound polyribosomes [24 (o), 32 (0) and 38 (A) A&ml] were isolated from livers of untreated mice 1121 and 
assayed for their ability to support methionine incorporation. Nuclease-treated lysate without exogenous RNA added was used as 
background (x). (B) As A, but with polyribosomes from clofibrate-treated animals. 
controls). Carnitine acetyltransferase, often used 
as a marker for peroxisome proliferation (although 
this protein is not exclusively localized to perox- 
isomes), displayed considerably increased activity 
(780% of control values). The relative levels of 
translated epoxide hydrolase were also increased 
1234 
Fig.2. Immunochemical nalysis of different fractions. (A) Antibodies against cytosolic epoxide hydrolase were used to probe Western 
blots of electrophoretically separated liver homogenate (lane 1) (lOO~g), light mitochondrial fraction (lane 2) (25pg), and cytosol (lane 
3) (30 /cg) from control mice and purified cytosolic epoxide hydrolase (lane 4) (0.5 cg). Lane 5 shows an autoradiograph of an im- 
munoprecipitate, from an in vitro translation assay with free polyribosomes 1121. The dot next to lane 1 indicates the band of interest 
in each panel. (B) As A but with antibodies against rat liver catalase. Lane 4 contains an immunoprecipitate from an in vitro translation 
assay with free polyribosomes. (C) Antibodies towards human serum albumin were used to immunoprecipitate translation products 
from membrane-bound polyribosomes (lane l), free polyribosomes (lane 3) prepared by magnesium precipitation and free poly- 
ribosomes (lane 2) prepared by sucrose gradient centrifugation. 
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Fig.3. Effects of clofibrate treatment on in vitro translation. 
Free polyribosomes were isolated [14] from control animals (o) 
and animals treated with clofibrate for 1 (A), 2 (o), 4 (+) and 7 
(m) days. Immunoprecipitation of catalase (cat) and epoxide 
hydrolase (eh) was performed at the 30 min time point for the 
different preparations. Values shown are means of two ex- 
periments. 
about 2-fold, whereas those of catalase were not 
changed significantly. 
To examine further the effects of clofibrate on in 
vitro translation, we analyzed free polyribosomes 
isolated from animals treated for 1, 2,4 and 7 days 
with dietary clofibrate. As shown in fig.3, clo- 
fibrate treatment increased the relative transla- 
tional efficiency at all time points analyzed. Max- 
imum translation was obtained after 2 days and 
then decreased after 4 and 7 days, but remained 
above control levels. The relative expression of 
soluble epoxide hydrolase changed similarly, al- 
though the change in relative levels, as calculated 
from the actual radioactivity (80-100% over con- 
trol), was not as pronounced as is suggested by the 
fluorographic image (fig.3). 
4. DISCUSSION 
Procedures originally established for the isola- 
tion of rat liver polyribosomes were effective for 
isolation of mouse liver polyribosomes with high 
translational activities as well. Although the 
method involving sucrose density gradient cen- 
trifugation of polyribosomes is time-consuming, it 
appears to result in preparations with lower con- 
tamination of membrane-bound polyribosomes 
(fig.2C) and in pure polyribosomes (~260/~280 = 
1.78 + 0.05, n = 11). The procedure using 
magnesium precipitation is faster and can be 
employed with non-starved animals (necessary in 
the time course experiments), however it results in 
less pure polyribosomes (&O/&W = 1.60 * 0.10, 
n = 25). At high concentrations these polyribo- 
somes also show a tendency to aggregate with time. 
Even though cross-contamination of free poly- 
ribosomes with membrane-bound polyribosomes 
occurs (cf. synthesis of albumin) and vice versa, the 
difference in relative levels of expression makes it 
possible for one to conclude that the cytosolic and 
peroxisomal forms of epoxide hydrolase are syn- 
thesized on free polyribosomes (fig.2). In contrast, 
microsomal epoxide hydrolase is synthesized on 
membrane- bound polyribosomes in rat liver [19]. 
Approximately the same relative expression of 
catalase and soluble epoxide hydrolase was found 
for the different polyribosome classes, which con- 
firms other data suggesting free polyribosomes to 
be the site of synthesis of catalase in rat liver [20]. 
The cytosolic and peroxisomal forms of epoxide 
hydrolase cannot be distinguished using the 
methods applied thus far (regarding substrate 
specificity, immunochemical reactivity, native and 
subunit molecular masses, isoelectric point and 
sensitivity to inhibitors; summarized in [l]), nor 
could more than one primary translation product 
be observed on SDS-polyacrylamide gel electro- 
phoresis (even after short exposure times in 
fluorography, minimizing blurring, only one band 
was observed). Thus, these two forms seem to be 
very similar to one another. Recent data also sug- 
gest that a large portion of the cytosolic epoxide 
hydrolase is in fact derived from peroxisomes, 
damaged during in vitro fractionation [21]. Of the 
peroxisomal proteins analyzed to date, only one 
protein, acyl-CoA thiolase, seems to be processed 
in mammalian liver after uptake into peroxisomes 
[20]. The peroxisomal epoxide hydrolase appears 
to conform to the general rule, judging from com- 
parison of the sizes of the radiolabelled primary 
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translation product and the stained mature protein. 
However, import experiments on newly synthesiz- 
ed proteins into peroxisomes have not yet been per- 
formed. 
Treatment of mice with the peroxisome pro- 
liferator clofibrate gives rise to massive prolifera- 
tion of peroxisomes in hepatocytes, however the 
peroxisomal proteins are induced to widely differ- 
ing extents [20]. The relative levels of soluble epox- 
ide hydrolase synthesized were shown to increase 
after clofibrate treatment (table 1, fig.3), sug- 
gesting an increase in transcription or mRNA 
stability. An interesting observation was the in- 
creased translational efficiency of polyribosomes 
isolated from clofibrate-treated animals (figs. 1,3). 
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